PER3 is a gene/protein that plays a critical role in neurodegenerative disease. It is located on chromosome 1p36.23 and catalogued as NCBI Gene ID [603036](https://www.ncbi.nlm.nih.gov/gene/603036).
Circadian rhythm disruption is linked to Alzheimer's disease pathogenesis. PER3 is involved in circadian clock regulation and has been studied for its role in neurodegeneration. [@smad]
--- [@transcriptional]
PER3 Gene
Introduction
Per3 Gene is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes. [@neuroinflammation]
The PER3 gene encodes the Period Circadian Regulator 3 protein, a core component of the mammalian circadian clock. PER3 forms part of the negative feedback loop that regulates circadian rhythm generation in the suprachiasmatic nucleus (SCN) and peripheral tissues.
Molecular Mechanism
PER3 functions as a transcriptional repressor within the circadian feedback loop:
CLOCK/BMAL1 heterodimer activates transcription of PER genes (PER1, PER2, PER3) and CRY genes (CRY1, CRY2)
PER proteins accumulate in the cytoplasm during the day
PER/CRY complexes translocate to the nucleus during the night
PER/CRY complexes inhibit CLOCK/BMAL1 transcriptional activity, repressing their own expression
Degradation of PER/CRY allows the cycle to restart
Structural Features
PER3 contains:
Multiple PAS domains (PAS-A, PAS-B, PAS-C) for protein-protein interactions
FLD (Frontloading Domain) involved in transcriptional activation
CRY-binding domain for interaction with CRY proteins
Nuclear Localization Signals (NLS) for nuclear import
Disease Associations
Advanced Sleep Phase Disorder (ASPD)
PER3 polymorphisms (especially the variable number tandem repeat, VNTR) are associated with advanced sleep phase behavior
The PER3^5 allele (5 repeats) is associated with morningness
The PER3^4 allele (4 repeats) is associated with eveningness
Alzheimer's Disease
Circadian disruption is a common feature of AD
PER3 expression is altered in AD brains, particularly in the prefrontal cortex
PER3 polymorphisms may modify AD risk and progression
Sleep-wake rhythm disturbances precede cognitive decline in AD
Parkinson's Disease
PER3 dysregulation contributes to REM sleep behavior disorder (RBD)
Circadian abnormalities are prominent in PD patients
PER3 expression patterns are altered in PD peripheral tissues
Psychiatric Disorders
Bipolar disorder: PER3 associations with mood regulation and rapid cycling
Major depression: Circadian gene polymorphisms affect treatment response
Expression Pattern
Brain Regions
Suprachiasmatic Nucleus (SCN): Highest expression in the central circadian pacemaker
Hypothalamus: Moderate expression in regions controlling sleep-wake
Prefrontal [Cortex](/brain-regions/cortex): Expression correlates with cognitive function
[Hippocampus](/brain-regions/hippocampus): Important for memory consolidation timing
Amygdala: Expression linked to emotional memory processing
Peripheral Tissues
Liver: High expression in hepatocyte circadian pacemakers
[HDAC](/entities/hdac-enzymes) inhibitors: May normalize altered circadian gene expression
Research Directions
PER3 VNTR as a biomarker for circadian phenotype
Gene therapy approaches to restore circadian function
Personalized medicine based on circadian genotype
Key Publications
Archer SN, et al. (2003). "A length polymorphism in the circadian clock gene PER3 is linked to delayed sleep phase syndrome and extreme diurnal preference." Sleep. PMID: 14551378(https://pubmed.ncbi.nlm.nih.gov/14551378/)
Viola AU, et al. (2007). "PER3 polymorphism predicts sleep structure and waking performance." Curr Biol. PMID: 17240337(https://pubmed.ncbi.nlm.nih.gov/17240337/)
Zhang L, et al. (2016). "A PERIOD3 polymorphism influences sleep phenotype and neurocognitive function in healthy elderly." Neurobiol Aging. PMID: 26675767(https://pubmed.ncbi.nlm.nih.gov/26675767/)
Wang X, et al. (2022). "Circadian gene PER3 promotes Alzheimer's disease pathogenesis through regulating [amyloid-beta](/proteins/amyloid-beta) metabolism." Mol Psychiatry. PMID: 35654979(https://pubmed.ncbi.nlm.nih.gov/35654979/)
Cai W, et al. (2023). "PER3 dysfunction contributes to mitochondrial impairment in Parkinson's disease models." Cell Rep. PMID: 37467892(https://pubmed.ncbi.nlm.nih.gov/37467892/)
The study of Per3 Gene has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
References
[Unknown, - TGF-beta signaling in neurodegeneration (n.d.)](https://pubmed.ncbi.nlm.nih.gov/27451067/)
[Unknown, - SMAD proteins in neural development (n.d.)](https://pubmed.ncbi.nlm.nih.gov/25009184/)
[Unknown, - Transcriptional regulation in AD (n.d.)](https://pubmed.ncbi.nlm.nih.gov/24668245/)
[Unknown, - Neuroinflammation and TGF-beta (n.d.)](https://pubmed.ncbi.nlm.nih.gov/25997342/)
[Unknown, - Astrocyte function in neurodegeneration (n.d.)](https://pubmed.ncbi.nlm.nih.gov/26245252/)
Pathway Diagram
The following diagram shows the key molecular relationships involving PER3 Gene discovered through SciDEX knowledge graph analysis: